Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AMMONIA N-13
- A Phase 1, Single-center, Double-blind, Placebo-controlled Study of TNP-2092 Capsules, and the Food Effect Study After Single-dose Oral Administration of TNP-2092 Capsules
- Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia
- Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy
- Effect of Adding Lamotrigine to Sodium Valproate in Childhood Epilepsy: Clinicolabratory Study
- Can Ammonium Inhalants Maintain Performance in Sleep Deprived Soldiers?
- Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy
- Efficacy of L-ornithine L-aspartate and Therapeutic Plasma Exchange Versus Plasma Exchange Alone in Lowering Ammonia and Improving Outcomes in Pediatric Acute Liver Failure.
- Comparing Nifuroxazide Plus Lactulose With Lactulose Alone in the Treatment of Hepatic Encephalopathy
- Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome
- Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)
- Myocardial Perfusion Imaging Galmydar Rest/Stress
- Glutamine and Traumatic Brain Injury
- Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy
- Clinical Study of DTX301 AAV- Mediated Gene Transfer for Ornithine Transcarbamylase(OTC) Deficiency
- Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
- The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
- Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
- Intravenous NAC Use in ACLF Patients
- Phase I Study of SGN1 in Patients With Advanced Solid Tumor
- Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
- Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome)
- Vitamin E Efficacy in HI/HA
- 18F-FMPP PET MPI in the Detection of Coronary Artery Disease
- Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
- Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)
- Long-term Efficacy of Carglumic Acid in Organic Acidemia.
- Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
- Use of HA 330-II for Hemofiltration in Patients With ALF as a Bridge to Liver Transplantation .
- MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function
- Safety and Tolerability of RTX-134 in Adults With Phenylketonuria
- Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.
- PEG3350 in ACLF With Hepatic Encephalopathy
- Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy
- UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder
- Trial of Rifaximin in Probable Alzheimer's Disease
- FMT in Cirrhosis and Hepatic Encephalopathy
- Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
- Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment
- HIPEC After Initial CRS in Patients Who Have Received NACT
- Safety, Tolerability and Pharmacodynamics of SYNB1020
- Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders
- Safety of PET MPI Using the CRCHUM N-13 Ammonia
- Manipulating the Gut Microbiome Study
- Hemodynamic Changes During Operative Hysteroscopy
- PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy
- A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.
- Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks
- To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure
- Manipulating the Gut Microbiome Study
- An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients
- Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF
- Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
- The Effects of Nitazoxanide in Hepatic Encephalopathy
- Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.
- Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
- Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study
- A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
- Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.
- Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
- Effective Treatments for Jellyfish Stings
- The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
- Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
- Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
- L-ornithine L-aspartate in Overt Hepatic Encephalopathy
- Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia
- Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
- Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
- The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
- Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
- Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers
- Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients
- Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress
- To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)
- Study of Sodium Bicarbonate in Kidney Transplant Recipients
- Acetyl-L-Carnitine In Severe Hepatic Encephalopathy
- Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
- Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
- Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
- Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
- Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders
- Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders
- Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)
- Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU
- Pathophysiology of Uric Acid Nephrolithiasis
- Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
- N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia
- Study of Lactulose in Children With Chronic Liver Disease
- Rifaximin Versus Lactulose in Renal Failure
- Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy
- Anaplerotic Therapy in Propionic Acidemia
- Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
- Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders
- A Possible Therapeutic Role for Adenosine During Inflammation
- Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure
- Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
- Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
- Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder
- Probiotics for the Prevention of Major Complications of Cirrhosis
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
- A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures
- Breath Ammonia Method for H. Pylori Detection: Phase II
- Endothelial Modulation for Angiogenic Therapy
Clinical trials list
click for details